Machine learning version of Martin-Hopkins equation matches accuracy of original LDL-C calculation
Clinical laboratories may soon be able to use a simplified LDL cholesterol calculation
Already a member? Log in here
Clinical Diagnostics Insider
(formerly Diagnostic Testing and Emerging Technologies)
Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
Using ‘Surfaceomics’ as a Jumping Point, a Case is Made for Clinical Lab Growth
Arun Wiita from USCF details his lab’s work using mass spectrometry
Already a member? Log in here
Diagnostics Pipeline: Cizzle Bio Introduces Test for Earlier Lung Cancer Detection
The CIZ1B biomarker blood-based assay has 95% sensitivity for detecting earliest stage of the cancer
Already a member? Log in here
Generative AI Struggles with Clinical Reasoning
Research shows that large language models lack reasoning skills required for clinical decision-making
Already a member? Log in here
Carbon Impact Report Shows Growing Lab Commitment to Reducing Carbon Emissions
Life sciences and clinical laboratories are accelerating zero-carbon goals, says My Green Lab CEO
Already a member? Log in here
Diagnostics Pipeline: Xella Health Launches Platform Focused on Women’s Medical Issues
The startup is trying to close the care gap between female and male patients
Already a member? Log in here
CAP Updates Guideline to Reduce Diagnostic Errors Through Structured Case Reviews
New evidence-based recommendations encourage pathology laboratories to formalize review processes
Already a member? Log in here
Growing Need for Companion Diagnostics is Evident at Drug Discovery Event
The momentum for targeted therapies has downstream implications for clinical laboratories
Already a member? Log in here
What the $1b Roche-PathAI Deal Can Tell Clinical Lab Directors
Roche acquires a workflow rather than a company, says AI industry observer
Already a member? Log in here
Diagnostics Pipeline: Expanded DPYD Test Anticipated to Make Chemotherapy Safer
Labcorp’s new genotyping test can identify gene variants that may make standard oncologic treatment deadly for some
Already a member? Log in here
Diagnostics Pipeline: To Gain Insight into Haystack MRD Test, Quest Works with City of Hope
New liquid biopsy assay will be used in conjunction with 500 cancer patients currently enrolled in clinical trials
Already a member? Log in here
Quest Diagnostics Launches Consumer-Facing AI on Its App and Portal
The company’s patients can use AI to look at trends going back five years
Already a member? Log in here
Thermo Fisher Scientific Debuts Pharmacogenetic Test to Improve Transplant Safety
Proper dosing helps prevent potential side effects such as developing diabetes and kidney damage
Already a member? Log in here
